← All trials
NCT03676569
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 15, 2015
- Primary completion
- Nov 10, 2019
- Completion date
- Nov 10, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 6
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Polish Academy of SciencesLead sponsor
- Polish Academy of SciencesReponsible party - principal investigator
- Institution of Mother and Child, Warsaw, PolandOverall official - principal investigator
- Institution of Mother and Child, Warsaw, PolandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.